Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Panacea Life Sciences Holdings, Inc. (PLSH : OTC)
 
 • Company Description   
Panacea Life Sciences is involved in production of legal, trace THC, hemp-derived cannabinoid products for consumers and pets. The company produces soft gels, gummies, tinctures, sublingual tablets, cosmetics and other topicals for purchase online and in stores as well as in smart kiosk vending machines. Panacea Life Sciences, formerly known as Exactus Inc., is based in DELRAY BEACH, FL.

Number of Employees: 35

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.49 Daily Weekly Monthly
20 Day Moving Average: 283 shares
Shares Outstanding: 14.76 (millions)
Market Capitalization: $7.23 (millions)
Beta: 3.77
52 Week High: $5.57
52 Week Low: $0.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.89% 0.35%
12 Week -45.43% -40.01%
Year To Date -31.94% -16.85%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5910 S University Blvd C18-193
-
Greenwood Village,FL 80121
USA
ph: 800-985-0515
fax: -
None http://www.exactushemp.com
 
 • General Corporate Information   
Officers
Leslie Buttorff - Chief Executive Officer; Principal Executive Offic
Nathan Berman - Principal Accounting Officer
Janice Nerger - Director
Lawrence J. Wert - Director
Alvaro Daniel Alberttis - Director

Peer Information
Panacea Life Sciences Holdings, Inc. (BJCT)
Panacea Life Sciences Holdings, Inc. (CADMQ)
Panacea Life Sciences Holdings, Inc. (APNO)
Panacea Life Sciences Holdings, Inc. (UPDC)
Panacea Life Sciences Holdings, Inc. (IMTIQ)
Panacea Life Sciences Holdings, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 69810P109
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 06/29/22
Share - Related Items
Shares Outstanding: 14.76
Most Recent Split Date: 10.00 (0.04:1)
Beta: 3.77
Market Capitalization: $7.23 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/29/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.73
Price/Cash Flow: -
Price / Sales: 3.59
EPS Growth
vs. Year Ago Period: 86.61%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -59.79%
ROE
03/31/22 - -102.83
12/31/21 - -82.97
09/30/21 - -129.08
ROA
03/31/22 - -32.99
12/31/21 - -25.98
09/30/21 - -36.08
Current Ratio
03/31/22 - 0.70
12/31/21 - 0.90
09/30/21 - 0.99
Quick Ratio
03/31/22 - -
12/31/21 - 0.48
09/30/21 - 0.38
Operating Margin
03/31/22 - -397.77
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -397.77
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -393.99
12/31/21 - -232.14
09/30/21 - -466.08
Book Value
03/31/22 - 0.28
12/31/21 - 0.33
09/30/21 - 0.39
Inventory Turnover
03/31/22 - 0.36
12/31/21 - 0.47
09/30/21 - 0.07
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©